Literature DB >> 12192602

N-myc modulates expression of p73 in neuroblastoma.

Xiaoxiang Zhu1, Katharina Wimmer, Rork Kuick, Barbara J Lamb, Stephanie Motyka, Rama Jasty, Valerie P Castle, Samir M Hanash.   

Abstract

The human p73 gene is a homolog of p53, which has been localized to chromosome 1p36 in a region that is frequently deleted in neuroblastoma. Transfection of the p73 gene into neuroblastoma cells that lack detectable p73 protein has been shown to result in growth suppression and to induce neuronal differentiation. In this study, we have identified by means of restriction landmark genome scanning (RLGS) a genomic fragment that was frequently reduced in intensity in neuroblastomas. The cloned fragment contained exon 1 of p73 as well as intronic and promoter sequences. We investigated the genomic and expression status of p73 and N-myc in 34 neuroblastoma tumors and 12 neuroblastoma cell lines. Approximately a third of neuroblastomas in our series exhibited deletion of p73. Most tumors analyzed exhibited reduced expression of p73, as determined by quantitative RT-PCR, in the absence of detectable p73 gene deletion. The reduced expression of p73 correlated with overexpression of N-myc in a statistically significant manner. The N-myc gene was transfected into two neuroblastoma cell lines that lacked N-myc amplification to determine its effect on p73 RNA levels. p73 was detectable at low level by RT-PCR in untransfected SK-N-AS cells and became undetectable following N-myc transfection, whereas in SH-EP1 cells, p73 levels were substantially reduced following transfection but remained detectable. Our data suggest that the N-myc gene modulates expression of p73, allowing neuroblastoma cells to escape the growth suppressing properties of p73.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12192602      PMCID: PMC1564122          DOI: 10.1038/sj.neo.7900255

Source DB:  PubMed          Journal:  Neoplasia        ISSN: 1476-5586            Impact factor:   5.715


  43 in total

1.  Polyamine buffer for bivariate human flow cytogenetic analysis and sorting.

Authors:  L S Cram; M Campbell; J J Fawcett; L L Deaven
Journal:  Methods Cell Biol       Date:  1990       Impact factor: 1.441

2.  N-myc amplification causes down-modulation of MHC class I antigen expression in neuroblastoma.

Authors:  R Bernards; S K Dessain; R A Weinberg
Journal:  Cell       Date:  1986-12-05       Impact factor: 41.582

3.  MatInd and MatInspector: new fast and versatile tools for detection of consensus matches in nucleotide sequence data.

Authors:  K Quandt; K Frech; H Karas; E Wingender; T Werner
Journal:  Nucleic Acids Res       Date:  1995-12-11       Impact factor: 16.971

4.  Importance of clinical exposure on verapamil enhancement of adriamycin-vincristine cytotoxicity in human neuroblastoma.

Authors:  L Helson; B Member; C Helson
Journal:  Cancer Drug Deliv       Date:  1984

5.  Over-expression of transfected N-myc oncogene in human SKNSH neuroblastoma cells down-regulates expression of beta 1 integrin subunit.

Authors:  R Judware; L A Culp
Journal:  Oncogene       Date:  1995-12-21       Impact factor: 9.867

6.  Allelic loss of chromosome 1p as a predictor of unfavorable outcome in patients with neuroblastoma.

Authors:  H Caron; P van Sluis; J de Kraker; J Bökkerink; M Egeler; G Laureys; R Slater; A Westerveld; P A Voûte; R Versteeg
Journal:  N Engl J Med       Date:  1996-01-25       Impact factor: 91.245

7.  Similarity of spontaneous germinal and in vitro somatic cell mutation rates in humans: implications for carcinogenesis and for the role of exogenous factors in "spontaneous" germinal mutagenesis.

Authors:  R D Kuick; J V Neel; J R Strahler; E H Chu; R Bargal; D A Fox; S M Hanash
Journal:  Proc Natl Acad Sci U S A       Date:  1992-08-01       Impact factor: 11.205

8.  There may be two tumor suppressor genes on chromosome arm 1p closely associated with biologically distinct subtypes of neuroblastoma.

Authors:  O Takeda; C Homma; N Maseki; M Sakurai; N Kanda; M Schwab; Y Nakamura; Y Kaneko
Journal:  Genes Chromosomes Cancer       Date:  1994-05       Impact factor: 5.006

9.  Human neuroblastoma cell lines that express N-myc without gene amplification.

Authors:  R K Wada; R C Seeger; G M Brodeur; P A Einhorn; S A Rayner; M M Tomayko; C P Reynolds
Journal:  Cancer       Date:  1993-12-01       Impact factor: 6.860

10.  Evidence for two tumour suppressor loci on chromosomal bands 1p35-36 involved in neuroblastoma: one probably imprinted, another associated with N-myc amplification.

Authors:  H Caron; M Peter; P van Sluis; F Speleman; J de Kraker; G Laureys; J Michon; L Brugières; P A Voûte; A Westerveld
Journal:  Hum Mol Genet       Date:  1995-04       Impact factor: 6.150

View more
  8 in total

1.  Focal adhesion kinase and p53 synergistically decrease neuroblastoma cell survival.

Authors:  Lauren A Gillory; Jerry E Stewart; Michael L Megison; Alicia M Waters; Elizabeth A Beierle
Journal:  J Surg Res       Date:  2015-03-14       Impact factor: 2.192

2.  Human cytomegalovirus infection of tumor cells downregulates NCAM (CD56): a novel mechanism for virus-induced tumor invasiveness.

Authors:  Roman A Blaheta; Wolf-Dietrich Beecken; Tobias Engl; Dietger Jonas; Elsie Oppermann; Michael Hundemer; Hans Wilhelm Doerr; Martin Scholz; Jindrich Cinatl
Journal:  Neoplasia       Date:  2004 Jul-Aug       Impact factor: 5.715

3.  Mcl1 downregulation sensitizes neuroblastoma to cytotoxic chemotherapy and small molecule Bcl2-family antagonists.

Authors:  Brian J Lestini; Kelly C Goldsmith; Mark N Fluchel; Xueyuan Liu; Niel L Chen; Bella Goyal; Bruce R Pawel; Michael D Hogarty
Journal:  Cancer Biol Ther       Date:  2009-08-08       Impact factor: 4.742

4.  Inhibition of focal adhesion kinase decreases tumor growth in human neuroblastoma.

Authors:  Elizabeth A Beierle; Xiaojie Ma; Jerry Stewart; Carl Nyberg; Angelica Trujillo; William G Cance; Vita M Golubovskaya
Journal:  Cell Cycle       Date:  2010-03-14       Impact factor: 4.534

5.  Mxi1-0, an alternatively transcribed Mxi1 isoform, is overexpressed in glioblastomas.

Authors:  Lars D Engstrom; Andrew S Youkilis; Judith L Gorelick; Datong Zheng; Valerie Ackley; Christy A Petroff; Linda Q Benson; Melissa R Coon; Xiaoxiang Zhu; Samir M Hanash; Daniel S Wechsler
Journal:  Neoplasia       Date:  2004 Sep-Oct       Impact factor: 5.715

6.  p73alpha isoforms drive opposite transcriptional and post-transcriptional regulation of MYCN expression in neuroblastoma cells.

Authors:  Emilie Horvilleur; Matthieu Bauer; David Goldschneider; Xénia Mergui; Alix de la Motte; Jean Bénard; Sétha Douc-Rasy; David Cappellen
Journal:  Nucleic Acids Res       Date:  2008-06-25       Impact factor: 16.971

Review 7.  Neuroblastoma: oncogenic mechanisms and therapeutic exploitation of necroptosis.

Authors:  S Nicolai; M Pieraccioli; A Peschiaroli; G Melino; G Raschellà
Journal:  Cell Death Dis       Date:  2015-12-03       Impact factor: 8.469

Review 8.  Cell death-based treatment of neuroblastoma.

Authors:  Kadri Valter; Boris Zhivotovsky; Vladimir Gogvadze
Journal:  Cell Death Dis       Date:  2018-01-25       Impact factor: 8.469

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.